124 assets in Fallopian Tube Cancer

Mirvetuximab Soravtansine

Adriamycin

Carboplatin

Irinotecan

Cis-Diamminedichloroplatinum Ii

Nogitecan

Cyclophosphamide

Docetaxel

Epirubicin

Olaparib

Cediranib

Pembrolizumab

Imnn-001

Jskn003

Letrozole

Nivolumab

Rucaparib

Etoposide

Niraparib

Atezolizumab

Gm-Csf

Goserelin

Isocyclophosphamide

Oxaliplatin

Pegfilgrastim

Dexasone

Durvalumab

Capecitabine

Dpx-Survivac

Fludarabine

Fluzoparib

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer

Rivoceranib

Decitabine

Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer

Fulvestrant

Ipilimumab

Phosphonic Acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-2,5-Dihydro-5-Oxo-1H-1,2,4-Triazol-1-Yl]-

Talazoparib

Aitua Combination Antibody

Benmelstobart

Catequentinib

Bl-M07D1

Dostarlimab

Fianlimab

Fluorouracilum

ibi354

Imiquimod

Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide

Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Cldn6 (Claudin 6, Claudin-6)], Monoclonal Antibody (Ixotatug)